Robin Harper Cowie

Robin Harper Cowie discloses dealings in Biodesix Inc to SEC (Form 4). We count 24 filings; the first trade dates from 17 November 2021 and the latest from 20 February 2026.

In open-market terms, that means 1 purchase worth €5,750 on one side and 1 sale worth €2,092 on the other. Netting one side against the other leaves €3,658 of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 20 option exercises. 2026 to date brings no purchases and 1 sale.

On 23 February 2026 came the latest disclosure, an option exercise in Biodesix Inc. The clock since the last published purchase (18 November 2021) now reads 1,795 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.